Organic & Biomolecular Chemistry
Page 4 of 4
4
For selected recent references to carbazole synthesis, see: (a) H-J.
Knoelker and K. R. Reddy in The Alkaloids (Ed. G. A. Cordell),
vol. 65, chapter 5, pp 195-210, Academic Press, 2008; (b) V. Nair,
N. Vidya, K. G. Abhilash and E. Suresh, Org. Biomol. Chem.,
2008, 6, 1738-1742; (c) M. E. Budén, V. A. Vaillard, S. E. Martin
and R. A. Rossi, J. Org. Chem., 2009, 74, 4490–4498.
(a) M. Sonntag and P. Strohriegl, Tetrahedron Lett., 2006, 47,
8313; (b) M. Sonntag and P. Strohriegl, Tetrahedron, 2006, 62,
8103.
I. K. Moon, C.-S. Choi, N. Kim, J. Polym. Sci. Pol. Chem., 2008,
46, 1783.
R5
H
Pd
X
R3
60
65
R4
N
5
Br
SEM
A
6
7
To sum up, this paper describes a general protocol for the
synthesis of dibenzo[a,c]carbazoles from 2-(2-bromoaryl)-3-
(a) D. Pelaprat, A. Delbarre, I. Le Guen, J. B. Le Pecq and B. P.
Roques, J. Med. Chem., 1980, 23, 1336; (b) E. Lescot, G. Muzard,
J. Markovits, J. Belleney, B. P. Roques, J.-B. Le Pecq, J. Med.
Chem., 1986, 29, 1731.
T. A. Engler, K. Furness, S. Malhotra, C. Sanchez-Martinez, C.
Shih, W. Xie, G.Zhu, X. Zhou, S. Conner, M. M. Faul, K. A.
Sullivan, S. T. Kolis, H. B. Brooks, B.Patel, R, M. Schultz, T, B.
DeHahn, K. Kirmani, C, D. Spencer, S. A. Watkins, E. L.
Considine, J. A. Dempsey, C. A. Ogg, N. B. Stamm, B. D.
Anderson, R. M. Campbell, V. Vasudevan and M. L. Lytlea,
Bioorg. Med. Chem. Lett., 2003, 13, 2261.
For recent reviews, see: (a) D. Alberico, M. E. Scott and M.
Lautens, Chem. Rev., 2007, 107, 174; (b) I. V. Seregin and V.
Gevorgyan, Chem. Soc. Rev., 2007, 36, 1173; (c) L.-C. Campeau,
D. R. Stuart and K. Fagnou, Aldrichimica Acta, 2007, 40, 35; (d) T.
Satoh and M. Miura, Chem. Lett., 2007, 36, 200; (e) H. M. L.
Davies and J. R. Mannins, Nature, 2008, 451, 417; (f) B.-J. Li, S.-
D. Yang and Z.-J. Shi, Synlett, 2008, 949; (g) F. Kakkiuchi and T.
Kochi, Synthesis, 2008, 3013; (h) C.-J. Li, Acc. Chem. Res., 2009,
42, 335; (i) G. P. McGlacken and L. M. Bateman, Chem. Soc. Rev.,
2009, 38, 2447; (j) P. Thansandote and M. Lautens, Chem. Eur. J.,
2009, 15, 5874; (k) X.; Chen, K. M. Engle, D.-H. Wang and J.-Q.
Yu, Angew. Chem. Int. Ed., 2009, 48, 5094; (l) O. Daugulis, H.-Q.
Do and D. Shabashov, Acc. Chem. Res., 2009, 42, 1074; (m) Y.
Zhou, J. Zhao and L. Liu, Angew. Chem. Int. Ed., 2009, 48, 7126;
(n) L. Ackermann, R. Vicente and A. R. Kapdi, Angew. Chem. Int.
Ed., 2009, 48, 9792; (o) T. W. Lyons and M. S. Sanford, Chem.
Rev., 2010, 110, 1147; (p) J. A. Ashenhurst, Chem. Soc. Rev.,
2010, 39, 540; (q) C.-L. Sun, B.-J. Li and Z.-I. Shi, Chem.
Commun., 2010, 46, 677; (r) M. Zhang, Appl. Organomet. Chem.,
2010, 24, 269; (s) A. Armstrong and J. C. Collins, Angew. Chem.
Int. Ed., 2010, 49, 2282.
5
arylindoles,
readily
available
from
2-[(2-
70
bromoaryl)ethynyl]trifluoroacetanilides. The reaction tolerates
a variety of useful substituents including chloro, nitro, ether,
cyano, keto, and ester groups and proceeds through an
intramolecular palladium-catalyzed C-H functionalization/C-
10 C bond formation process that most probably involves an
electrophilic aromatic substitution.
8
9
75
Acknowledgment
80
We gratefully acknowledge MURST and the University “La
Sapienza” for financial support.
15 Notes and references
85
a Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza,
Università di Roma, P.le A. Moro 5, 00185 Rome, Italy. Fax: +39 (06)
4991 2780; Tel: +39 (06) 4991 2795; E-mail:
90
20 † Electronic Supplementary Information (ESI) available: [details of any
supplementary information available should be included here]. See
DOI: 10.1039/b000000x/
1
For recent reviews, see: (a) G. Battistuzzi, S. Cacchi and G.
Fabrizi, Eur. J. Org. Chem., 2002, 2671; (b) S. Cacchi and G.
Fabrizi, Chem. Rev., 2005, 105, 2873; (c) S. Cacchi and G. Fabrizi,
Chem. Rev., 2011, 111, PR215.
95
25
30
35
40
45
50
55
2
For selected references, see: (a) H. E. Katz, Z. Bao and S. L. Gilat,
Acc. Chem. Res., 2001, 34, 359; (b) C. D. Dimitrakopoulos and P.
R. L. Malenfant, Adv. Mater., 2002, 14, 99; (c) O. Ostroverkhova
and W. E. Moerner, Chem. Rev., 2004, 104, 3267; (d) S. Wakim, J.
Bouchard, N. Blouin, A. Michaud and M. Leclerc, Org. Lett.,
2004, 6, 3413; (e) K. Brunner, A. van Dijken, H. Börner, J. J. A.
M. Bastiaansen, N. M. M. Kiggen and B. M. W. Langeveld, J. Am.
Chem. Soc., 2004, 126, 6035; (f) D. E. Gingrich, S. X. Yang, G. W.
Gessner, T. S. Angeles and R. L. Hudkins, J. Med. Chem., 2005,
48, 3776; (g) Y. Li, Y. Wu, S. Gardner and B. S. Ong, Adv. Mater.,
2005, 17, 849; (h) N. Blouin and M. Leclerc, Acc. Chem. Res.,
2008, 41, 1110; (i) A. C. Grimsdale, K. L. Chan, R. E. Martin, P.
G. Jokisz and A. B. Holmes, Chem. Rev., 2009, 109, 897; (j) C. M.
Amb, A. L. Dyer and J. R. Reynolds, Chem. Mater., 2011, 23, 397;
(k) S. H. Jeong and J. Y. Lee, J. Mater. Chem., 2011, 21, 14604; (l)
S. H. Kim, I. Cho, M. K. Sim, S. Park and S. Y. Park, J. Mater.
Chem., 2011, 21, 9139; (m) S. H. Jeong and J. Y. Lee, J. Mater.
Chem., 2011,21, 14604.
See, for example: (a) D. J. Hook, J. J. Yacobucci, S. O’ Connor, M.
Lee, E. Kerns, B. Krishnan, J.; Matson and G. Hesler, J. Antibiot.,
1990, 43, 1347; (b) L. T. Zheng, J. Hwang, J. Ock, M. G. Lee, W.-
H. Lee and K. Suk, J. Neurochem., 2008, 107, 1225; (c) J. Cao, T.
Kopajtic, J. L. Katz, A. H. Newmana, Bioorg. Med. Chem. Lett.,
2008, 18, 5238; (d) S. Yang, N. J. Alkayed, P. D. Hurn and J. R.
Kirsch, Anesth. Analg., 2009, 108, 964; (e) M. G. Ferlin, C.
Marzano, V. Gandin, S. Dall’Acqua and L. Dalla Via, Chem. Med.
Chem., 2009, 4, 363; (f) J. Poljakova, T. Eckschlager, J. Hrabetă, J.
Hrĕbackŏvá, S. Smutný, E. Frei, V. Martínek, R. Kizek and M.
Stiborová, Biochem. Pharmacol., 2009, 77, 1466.
10 A. Arcadi, S. Cacchi, F. Marinelli, Tetrahedron Lett., 1989, 30,
2581.
100
105
11 M. Netherton and G. C. Fu, Org. Lett. 2001, 3, 4295.
12 The Heck-like insertion of the initially formed oxidative addition
intermediate in the palladium-catalyzed arylation has been shown
to be rather unlikely: C. C. Hughes and D. Trauner, Angew. Chem.
Int. Ed., 2002, 41, 1569.
3
4
| Journal Name, [year], [vol], 00–00
This journal is © The Royal Society of Chemistry [year]